Prostate Cancer Diagnosis Advancements

Posted by Admin on February 22, 2011

Prostate cancer can be tricky to diagnosis, and because of it 40% of men with prostate cancer may be unaware they have it, according to researcher by the Prostate Cancer Foundation in Chicago. However, new innovations in diagnostics that have recently been developed that can help improve those numbers. Researchers at Eindhoven University of Technology (TU/e) in the Netherlands, in cooperation with AMC Amsterdam, have developed a new imaging technology based on ultrasound that can more accurately indentify tumors.

At the Prostate Cancer Foundation they have developed a new biopsy procedure based on a four year study of 747 patients with elevate prostate specific antigen (PSA) levels. The director of the Foundation, Michelle Bacioforte, claims, “Men who have negative transrectal biopsies and continue to have elevated PSA levels should consider STPB because 40% will harbor malignancy. Our level of confidence is greatly enhanced with regards to the presence or absence of cancer, and more specifically, the exact location of the cancer within the prostate.” Then researchers utilized an advanced biopsy technique called stereotactic transperineal prostate biopsy (STPB). The biopsy results identified the presence of cancer in 291 (395) of the patients.

"The information obtained from this kind of comprehensive biopsy allows us to design and perform more sophisticated treatment plans", says Dr. Brian Moran, medical director of the Prostate Cancer Foundation of Chicago and the Chicago Prostate Cancer Center.  This procedure is also a stepping stone towards focal therapy, where more limited treatment can result in less side effects, yet achieve cure rates equal to more radical forms of treatment. "

Prostate cancer is one of the most common causes of death in men in the western world. In the United States each year 200,000 men are diagnosed with prostate cancer. New advancements in prostate cancer diagnosis are important steps towards saving lives. 



Subscribe to our newsletter

Enter your email address to subscribe and receive notifications of new stories on

Sponsored by

Call 888-885-0531 to
Discuss Your Treatment Options
Hear From Our Cancer Survivors
First Name:
Last Name: